Table 4 reveals a highly significant lower rate of FGFR3 mutations in the present Chinese UBC patient group despite the vast majority of them being in stage pTa/T1 compared to patients in van Oers’ cohort.
← all excerpts
The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent FGFR3 mutation in Han Chinese patients.
1
—
—